Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00057941
What this trial is testing

Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerProgesterone Receptor-positive Breast CancerRecurrent Breast Cancer+1 more
National Cancer Institute (NCI) 148
Large-scale testing (Phase 3)UnknownNCT01104571
What this trial is testing

Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 257
Early research (Phase 1)Study completedNCT03554044
What this trial is testing

T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+11 more
University of California, San Francisco 20
Testing effectiveness (Phase 2)Ended earlyNCT01207102
What this trial is testing

Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT03078751
What this trial is testing

Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 54
Not applicableUnknownNCT00625001
What this trial is testing

Long Term Follow-up of Bone Mineral Density in Hormone Treated Turner Syndrome

Who this might be right for
Turner Syndrome
University of Aarhus 54
Testing effectiveness (Phase 2)Ended earlyNCT04965688
What this trial is testing

Biology Guided Therapy for Breast Cancer for ER Positive

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast CancerHER2-negative Breast Cancer
Inova Health Care Services 2
Not applicableUnknownNCT03351205
What this trial is testing

The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis

Who this might be right for
Intrauterine Adhesion
Beijing Obstetrics and Gynecology Hospital 100
Post-approval studies (Phase 4)Looking for participantsNCT05515354
What this trial is testing

Smoking Cessation and Menstrual Cycle Phase

Who this might be right for
Nicotine DependenceTobacco SmokingSmoking Cessation+2 more
Centre for Addiction and Mental Health 1,200
Large-scale testing (Phase 3)Study completedNCT00785291
What this trial is testing

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+6 more
National Cancer Institute (NCI) 799
Testing effectiveness (Phase 2)Study completedNCT03809988
What this trial is testing

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)

Who this might be right for
Breast CancerAdvanced Breast CancerHormone Receptor Positive Tumor+1 more
MedSIR 198
Not applicableWithdrawnNCT02383823
What this trial is testing

Postprandial Lipidemia After a Meal With Different Types of Fat, Estrogen Treatment, Age and Gender in Healthy Subjects

Who this might be right for
Menopause
Herning Hospital
Large-scale testing (Phase 3)WithdrawnNCT01724242
What this trial is testing

Vaginal DHEA for Women After Breast Cancer

Who this might be right for
Vaginal DrynessBreast CancerUrinary Incontinence+2 more
Hadassah Medical Organization
Testing effectiveness (Phase 2)Study completedNCT00631124
What this trial is testing

Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles

Who this might be right for
Contraception
Bayer 103
Large-scale testing (Phase 3)Active Not RecruitingNCT05296798
What this trial is testing

Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Who this might be right for
Locally Advanced or Metastatic Breast Cancer
Hoffmann-La Roche 922
Not applicableNot Yet RecruitingNCT07795606
What this trial is testing

An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes

Who this might be right for
Estrogen Therapy
Bayer 456,000
Testing effectiveness (Phase 2)Study completedNCT00084396
What this trial is testing

Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Who this might be right for
Breast Cancer
Washington University School of Medicine 115
Testing effectiveness (Phase 2)UnknownNCT04853069
What this trial is testing

Oestrogen Treatment for COVID-19 Symptoms

Who this might be right for
COVID-19
Hamad Medical Corporation 2,000
Testing effectiveness (Phase 2)Study completedNCT01855971
What this trial is testing

"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome" (TESFX)

Who this might be right for
Fragile X Syndrome
Parc de Salut Mar 44
Post-approval studies (Phase 4)Study completedNCT01329562
What this trial is testing

CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

Who this might be right for
Menstrual Migraine
Cady, Roger, M.D. 41
Next Page